- Home
- TARS vs PRVA Comparison
TARS vs PRVA Comparison
Compare TARS & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | PRVA |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARS | PRVA |
|---|---|---|
| Price | $75.30 | $23.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $80.56 | $30.50 |
| AVG Volume (30 Days) | 616.6K | ★ 689.4K |
| Earning Date | 06-01-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $451,360,000.00 | ★ $1,736,390,000.00 |
| Revenue This Year | $51.34 | $23.19 |
| Revenue Next Year | $29.34 | $13.51 |
| P/E Ratio | ★ N/A | $225.45 |
| Revenue Growth | ★ 146.71 | 4.74 |
| 52 Week Low | $38.51 | $18.78 |
| 52 Week High | $85.25 | $26.51 |
Technical Indicators
Market Signals| Indicator | TARS | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 57.71 |
| Support Level | $65.62 | $23.72 |
| Resistance Level | $76.81 | $25.08 |
| Average True Range (ATR) | 3.86 | 0.90 |
| MACD | 1.80 | 0.30 |
| Stochastic Oscillator | 75.85 | 66.11 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.